
Exploris Health provides non-invasive diagnostic tests powered by AI to identify heart disease more affordably. Its Cardio Explorer uses AI-generated multi-marker algorithms to detect coronary artery disease with precision comparable to CT or MRI. The product is offered as Software as a Medical Device (SaaS SaMD) and targets healthcare providers. It is designed for clinical workflows and hospital information systems to enable scalable deployment. Beyond cardiology, the company plans additional algorithms for heart failure and cancer, aiming to scale across the healthcare market.

Exploris Health provides non-invasive diagnostic tests powered by AI to identify heart disease more affordably. Its Cardio Explorer uses AI-generated multi-marker algorithms to detect coronary artery disease with precision comparable to CT or MRI. The product is offered as Software as a Medical Device (SaaS SaMD) and targets healthcare providers. It is designed for clinical workflows and hospital information systems to enable scalable deployment. Beyond cardiology, the company plans additional algorithms for heart failure and cancer, aiming to scale across the healthcare market.
Headquarters: Wallisellen (Zurich), Switzerland
Founded: 2018
Flagship product: Cardio Explorer — CE‑marked AI-based multi-marker diagnostic for coronary/heart disease
Business model: Software as a Medical Device (SaaS SaMD) targeting healthcare providers
Employees (approx.): 14
Cardiology diagnostics and therapy support using AI-generated multi-marker algorithms to detect heart disease non-invasively.
2018
Biotechnology
Last reported funding type listed as Convertible Note